TCM
PTCT icon

Tygh Capital Management’s PTC Therapeutics PTCT Stock Holding History

Tygh Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.85M Sell
46,372
-100
-0.2% -$3.83K 0.24% 78
2021
Q3 		$1.73M Buy
46,472
+8,189
+21% +$336K 0.23% 86
2021
Q2 		$1.62M Sell
38,283
-396
-1% -$17K 0.22% 84
2021
Q1 		$1.83M Buy
38,679
+1,539
+4% +$91.4K 0.26% 84
2020
Q4 		$2.27M Buy
37,140
+348
+0.9% +$20.5K 0.35% 84
2020
Q3 		$1.72M Buy
+36,792
New +$1.81M 0.33% 82

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tygh Capital Management's PTCT Position: Q4 2021 in Review

Tygh Capital Management reduced its PTC Therapeutics (PTCT) stake by 0.22% in Q4 2021, selling an estimated $3.83K and leaving 46,372 shares worth $1.85M. The position accounts for 0.24% of the portfolio, ranked #78.

Tygh Capital Management first reported a position in PTCT in Q3 2020 and has held it in 6 quarters since. The position peaked at $2.27M in Q4 2020. 179 funds tracked by Wall St. Rank hold PTCT as of Q4 2021.

  • Tygh Capital Management held 46,372 shares of PTC Therapeutics worth $1.85M as of Q4 2021.
  • Tygh Capital Management sold 100 PTC Therapeutics shares in Q4 2021, an estimated $3.83K.
  • PTC Therapeutics made up 0.24% of Tygh Capital Management's portfolio in Q4 2021, its #78 holding.
  • Tygh Capital Management first reported a position in PTC Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • Tygh Capital Management's PTC Therapeutics position peaked at $2.27M in Q4 2020.
  • 179 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.